GO:0008617 guanosine metabolic process: Purine Nucleoside Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008617 (guanosine metabolic process) describes the chemical reactions and pathways involving guanine, guanine riboside, and related nucleosides, which are widely distributed across species.
• Guanosine metabolism supplies the building blocks for RNA, DNA, and nucleotide cofactors, and its intermediates participate in tRNA and mRNA modification.
• Methylated guanosine derivatives such as 7-methylguanosine are essential for tRNA stability, mRNA cap function, and translation fidelity.
• Dysregulated guanosine metabolism and its modified derivatives are linked to cancer progression, mitochondrial dysfunction, and neurological disorders.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of guanosine metabolic enzymes and transporters.
• Metabolic engineering of guanosine biosynthesis in Escherichia coli demonstrates that this pathway is tractable for industrial and synthetic biology applications.
Description
Guanosine metabolic process (GO:0008617) is a biological process ontology term that encompasses the chemical reactions and pathways involving guanine, guanine riboside, and related nucleosides, which have a wide species distribution. Guanosine is a purine nucleoside composed of guanine linked to a ribose sugar, and its metabolism intersects with nucleotide biosynthesis, salvage, and modification pathways that are fundamental to all cellular life. Understanding this process is important because guanosine and its derivatives are not only building blocks of RNA and DNA but also critical regulators of translation, signaling, and mitochondrial function. Research on guanosine metabolic process has revealed that modified guanosine species, such as 7-methylguanosine, play essential roles in tRNA stability, mRNA cap formation, and codon-anticodon interactions. These modifications are dynamically regulated and their perturbation can lead to human diseases, including cancer and neurological disorders. Moreover, the guanosine biosynthetic pathway is a target for metabolic engineering, as demonstrated by the efficient production of guanosine in Escherichia coli through combinatorial metabolic engineering. For researchers, GO:0008617 provides a framework to systematically study the enzymes, transporters, and regulatory mechanisms that control guanosine homeostasis. This article integrates authoritative QuickGO annotation with real PubMed literature to outline the definition, mechanisms, key genes, disease links, and experimental models relevant to guanosine metabolic process.
guanosine metabolic process At A Glance
| GO ID | GO:0008617 |
|---|---|
| GO term | guanosine metabolic process |
| Ontology | biological_process |
| Synonym | guanosine metabolism |
| Definition | The chemical reactions and pathways involving guanine, guanine riboside, a nucleoside with a wide species distribution. |
| Major function | Production and interconversion of guanosine and its modified derivatives for RNA, DNA, and cofactor biosynthesis. |
| Related modifications | 7-methylguanosine in tRNA and mRNA cap structures. |
| Species distribution | Widely distributed across bacteria, eukaryotes, and archaea. |
| Disease relevance | Cancer, mitochondrial dysfunction, and neuroregeneration. |
What Is GO:0008617?
According to the Gene Ontology, guanosine metabolic process (GO:0008617) is defined as the chemical reactions and pathways involving guanine, guanine riboside, a nucleoside with a wide species distribution. In other words, it covers all enzymatic and transport steps that synthesize, modify, salvage, or degrade guanosine and its derivatives within a cell.
Why Is guanosine metabolic process Important in Cell Biology?
Guanosine metabolic process is central to cellular life because it provides guanosine nucleotides for nucleic acid synthesis and supplies modified guanosine derivatives that regulate translation and RNA stability. Defects in this pathway can impair mitochondrial function, promote tumor progression, and affect neuronal survival, making it a key area for both basic and translational research.
• Supplies guanosine triphosphate (GTP) for RNA and DNA synthesis and for signaling GTPases.
• Generates 7-methylguanosine modifications essential for tRNA stability and mRNA cap function.
• Regulates translation fidelity through modified guanosine in tRNA anticodon loops.
• Supports mitochondrial oxidative phosphorylation via tRNA modification-dependent mechanisms.
• Plays a role in neuroprotection and neuroregeneration through purine nucleoside signaling.
• Is a target for metabolic engineering to produce guanosine industrially.
• Dysregulation is associated with gastric cancer progression.
• Impacts spliceosomal snRNP biogenesis through nuclear import of RNA-protein complexes.
• Provides a model for studying self-splicing group I introns that use guanosine as a cofactor.
• Enables CRISPR-based functional genomics of purine metabolic networks.
What Happens During guanosine metabolic process?
De novo biosynthesis of guanosine nucleotides
In simple terms: The cell builds guanosine from scratch using a series of enzymatic steps.
De novo purine biosynthesis generates inosine monophosphate (IMP), which is then converted to guanosine monophosphate (GMP) through the sequential action of IMP dehydrogenase and GMP synthase. This pathway is essential for providing guanosine nucleotides when salvage is insufficient. Metabolic engineering of Escherichia coli has demonstrated that combinatorial optimization of these biosynthetic steps can significantly enhance guanosine production.
Salvage and interconversion of guanosine
In simple terms: The cell recycles guanosine from degraded RNA or nucleotides.
Salvage pathways recover guanosine and guanine from nucleic acid turnover. Purine nucleoside phosphorylase and hypoxanthine-guanine phosphoribosyltransferase interconvert guanosine, guanine, and GMP. These reactions maintain cellular guanosine pools and are critical for nucleotide homeostasis. Purine nucleosides, including guanosine, have been implicated in neuroregeneration and neuroprotection, highlighting their signaling roles beyond biosynthesis.
Modification of guanosine in RNA
In simple terms: Guanosine can be chemically modified after it is incorporated into RNA.
Guanosine residues in tRNA and mRNA are subject to methylation and other modifications. 7-Methylguanosine (m7G) is a prominent modification found in tRNA and mRNA caps. In tRNA, m7G modifications influence stability and decoding, while in mRNA, the m7G cap is essential for translation initiation and stability. N7-methylguanosine tRNA modification promotes gastric cancer progression by activating SDHAF4-dependent mitochondrial oxidative phosphorylation. Additionally, an RNA modification prevents extended codon-anticodon interactions from facilitating +1 frameshifting, underscoring the role of modified guanosine in translation fidelity.
Guanosine as a cofactor in RNA splicing
In simple terms: Guanosine helps some RNA molecules cut and join themselves.
Group I introns undergo self-splicing in a reaction that requires an external guanosine nucleotide as a cofactor. The 3'-hydroxyl group of guanosine attacks the 5' splice site, initiating the splicing cascade. This mechanism, first described for the Tetrahymena rRNA intron, illustrates a fundamental role of guanosine in RNA processing.
Nuclear import and snRNP assembly
In simple terms: Guanosine-related nucleotides are part of the machinery that builds spliceosomes.
Spliceosomal small nuclear ribonucleoproteins (snRNPs) contain modified nucleotides, including guanosine derivatives, that are important for their assembly and function. Nuclear import of spliceosomal snRNPs is a regulated process that ensures proper splicing activity. Although the direct role of guanosine metabolism in snRNP assembly is not fully defined, the presence of modified guanosines in snRNA suggests a connection.
Key Genes Involved in GO:0008617 guanosine metabolic process
The following genes and proteins are experimentally implicated in guanosine metabolic process and its regulation, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IMPDH | Converts IMP to XMP in de novo GMP synthesis | Target for metabolic engineering and cancer therapy |
| GMP synthase | Converts XMP to GMP | Key enzyme in guanosine biosynthesis |
| Purine nucleoside phosphorylase | Reversibly converts guanosine to guanine and ribose-1-phosphate | Salvage pathway and neuroprotection |
| HGPRT | Salvages guanine to GMP | Lesch-Nyhan syndrome and purine metabolism |
| m7G methyltransferase | Adds methyl group to guanosine in tRNA and mRNA cap | Cancer progression and translation regulation |
| SDHAF4 | Mitochondrial oxidative phosphorylation assembly factor | Downstream target of m7G tRNA modification in cancer |
| tRNA modification enzymes | Install m7G and other modifications in tRNA | Translation fidelity and frameshifting |
| mRNA cap methyltransferase | Methylates guanosine cap of mRNA | mRNA stability and translation |
| Group I intron ribozymes | Self-splicing using guanosine cofactor | RNA catalysis and evolution |
| SnRNP import receptors | Mediate nuclear import of spliceosomal snRNPs | Splicing regulation |
| Purine transporters | Uptake of guanosine and related nucleosides | Neurosignaling and drug delivery |
| GTPases | Utilize GTP derived from guanosine metabolism | Signal transduction |
| Ribonucleotide reductase | Converts GDP to dGDP for DNA synthesis | Cell cycle and DNA repair |
| Adenosine deaminase | Purine catabolism intersecting with guanosine | Immunodeficiency and metabolism |
| Xanthine oxidase | Degrades guanine to xanthine | Uric acid production and gout |
| Guanylate kinase | Phosphorylates GMP to GDP | Nucleotide homeostasis |
| Nucleoside diphosphate kinase | Converts GDP to GTP | Energy metabolism and signaling |
| m7G tRNA methyltransferase complex | Catalyzes m7G modification in tRNA | Cancer and mitochondrial function |
How Is guanosine metabolic process Regulated?
Guanosine metabolic process is regulated at multiple levels. Transcription of biosynthetic enzymes is controlled by purine-responsive regulators, while feedback inhibition by GMP and GTP modulates enzyme activity. In eukaryotes, mTOR signaling influences nucleotide synthesis to match cell growth demands. Additionally, the expression and activity of m7G methyltransferases are regulated in response to stress and oncogenic signals, affecting tRNA modification and mitochondrial function. The interplay between guanosine metabolism and signaling pathways ensures balanced nucleotide pools for RNA and DNA synthesis.
guanosine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| m7G tRNA methyltransferase | Gastric cancer progression | Knockout in gastric cancer cell lines |
| SDHAF4 | Mitochondrial oxidative phosphorylation | Knockdown and overexpression in cancer cells |
| Purine nucleoside phosphorylase | Neurodegeneration | Knockout mice and neuronal cultures |
| HGPRT | Lesch-Nyhan syndrome | Point mutation knock-in in iPSCs |
| SnRNP import receptors | Splicing defects | Knockout in HeLa cells |
Cancer
Dysregulated guanosine metabolism contributes to cancer progression. N7-methylguanosine tRNA modification promotes gastric cancer progression by activating SDHAF4-dependent mitochondrial oxidative phosphorylation. This modification enhances mitochondrial function and supports tumor growth, suggesting that targeting m7G tRNA modification enzymes could be a therapeutic strategy. Additionally, altered guanosine nucleotide pools can affect DNA synthesis and repair, influencing chemoresistance.
Neurodegeneration and neuroprotection
Purine nucleosides, including guanosine, have neuroprotective and neuroregenerative properties. Guanosine modulates glutamate uptake, reduces oxidative stress, and promotes neurite outgrowth in models of Parkinson's disease, Alzheimer's disease, and stroke. These effects are mediated through adenosine receptors and other signaling pathways, highlighting the therapeutic potential of guanosine-based compounds.
Mitochondrial dysfunction
Mitochondrial oxidative phosphorylation relies on properly modified tRNAs, including those carrying m7G. Defects in guanosine modification can impair mitochondrial translation and lead to mitochondrial dysfunction, which is implicated in metabolic disorders and cancer.
Ribosomopathies and splicing defects
Guanosine derivatives are essential for snRNP assembly and splicing. Disruption of nuclear import of spliceosomal snRNPs can cause splicing defects associated with diseases such as spinal muscular atrophy and retinitis pigmentosa. Although direct links to guanosine metabolism are still emerging, the role of modified guanosines in snRNA suggests a potential connection.
From guanosine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate guanosine biosynthesis? | CRISPR knockout in E. coli or mammalian cells |
| What is the effect of a point mutation in a guanosine metabolic enzyme? | CRISPR point mutation knock-in |
| How does overexpression of m7G methyltransferase affect translation? | CRISPR overexpression cell lines |
| Can we tag endogenous guanosine metabolic enzymes for imaging? | Tagged knock-in with fluorescent protein |
| What is the role of guanosine in neuroprotection? | Knockout mice and primary neurons |
| How does m7G modification affect codon-anticodon interactions? | Ribo-seq and tRNA sequencing in knockout cells |
How to Study the guanosine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Translation efficiency and ribosome occupancy | Assessing impact of m7G on translation |
| tRNA-seq | tRNA abundance and modification status | Quantifying m7G levels in tRNA |
| LC-MS metabolomics | Guanosine and nucleotide concentrations | Measuring pathway flux |
| CRISPR knockout screens | Gene essentiality and pathway dependencies | Identifying novel regulators |
| Fluorescent GTP biosensor | Real-time GTP dynamics | Live-cell imaging |
| Western blot | Protein expression of metabolic enzymes | Validating knockout or overexpression |
| Immunofluorescence | Subcellular localization | Tagged knock-in imaging |
| Seahorse assay | Mitochondrial oxidative phosphorylation | Assessing SDHAF4-dependent function |
Ribo-seq and tRNA sequencing
Ribosome profiling (Ribo-seq) measures translation efficiency and can reveal the impact of guanosine modifications on codon-anticodon interactions and frameshifting. tRNA sequencing detects modified nucleotides, including m7G, and quantifies changes in tRNA modification status.
Metabolomics and flux analysis
Liquid chromatography-mass spectrometry (LC-MS) quantifies guanosine and its nucleotides, while isotope tracing reveals metabolic flux through de novo and salvage pathways. These methods are essential for assessing the impact of genetic perturbations on guanosine metabolism.
CRISPR screens and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for guanosine metabolism and sensitivity to metabolic inhibitors. Pooled screens coupled with sequencing enable unbiased discovery of pathway components.
Imaging and reporter assays
Fluorescent biosensors for GTP and guanosine can monitor real-time dynamics in live cells. Tagged knock-in of metabolic enzymes allows visualization of subcellular localization and interactions.
How CRISPR Can Be Used to Study GO:0008617 guanosine metabolic process
Knockout
CRISPR knockout of guanosine metabolic genes, such as IMPDH or m7G methyltransferases, enables loss-of-function studies to determine their role in nucleotide homeostasis, translation, and disease. Knockout cell lines can be used for metabolomic profiling and drug sensitivity assays.
Point Mutation
CRISPR point mutation knock-in introduces specific amino acid substitutions to dissect catalytic residues or regulatory phosphorylation sites in guanosine metabolic enzymes. This approach is valuable for modeling human mutations associated with disease.
Knock-in
Knock-in of fluorescent or affinity tags at endogenous loci allows visualization and purification of guanosine metabolic enzymes under native regulation. Tagged knock-in models are useful for interactome studies and live-cell imaging.
Overexpression
CRISPR-mediated overexpression of guanosine biosynthetic enzymes or m7G methyltransferases can enhance pathway flux and modify tRNA/mRNA modifications. Overexpression models are used to study gain-of-function effects in cancer and metabolic engineering.
How EDITGENE Supports guanosine metabolic process Research
Researchers studying guanosine metabolic process-related genes often need to determine whether a candidate gene is causally involved in nucleotide homeostasis, translation, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for guanosine metabolic process research.
Frequently Asked Questions About guanosine metabolic process
What is guanosine metabolic process?
Guanosine metabolic process (GO:0008617) is the set of chemical reactions and pathways involving guanine, guanine riboside, and related nucleosides, which are widely distributed across species.
What genes are involved in guanosine metabolic process?
Key genes include IMPDH, GMP synthase, purine nucleoside phosphorylase, HGPRT, and m7G methyltransferases, among others.
How is guanosine metabolic process regulated?
It is regulated by feedback inhibition, transcriptional control, and signaling pathways such as mTOR, as well as by RNA modification enzymes.
What diseases are associated with guanosine metabolic process?
Dysregulation is linked to cancer, neurodegeneration, mitochondrial dysfunction, and splicing defects.
What is the role of 7-methylguanosine in guanosine metabolism?
7-Methylguanosine is a modified guanosine found in tRNA and mRNA caps, important for stability, translation, and cancer progression.
How can CRISPR be used to study guanosine metabolic process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes in this pathway.
What methods are used to study guanosine metabolism?
Common methods include Ribo-seq, tRNA-seq, LC-MS metabolomics, CRISPR screens, and imaging with fluorescent biosensors.
Why is guanosine metabolism important for cancer?
m7G tRNA modification promotes gastric cancer progression by activating mitochondrial oxidative phosphorylation, highlighting a role in tumor metabolism.
Is guanosine involved in neuroprotection?
Yes, guanosine and other purine nucleosides have neuroprotective and neuroregenerative effects in models of neurodegenerative diseases.
Can guanosine be produced industrially?
Yes, metabolic engineering of Escherichia coli has achieved efficient guanosine production through combinatorial pathway optimization.
Conclusion
Guanosine metabolic process (GO:0008617) is a fundamental biological process that encompasses the synthesis, salvage, modification, and utilization of guanosine and its derivatives. Its importance spans nucleic acid metabolism, translation regulation, mitochondrial function, and neuroprotection, with direct implications for cancer and neurological diseases. Advances in CRISPR-based models and multi-omics methods are accelerating the functional annotation of this pathway, offering new opportunities for therapeutic intervention and metabolic engineering.
References
- 1. Zhang K et al.. 2024. Efficient production of guanosine in Escherichia coli by combinatorial metabolic engineering.. Microb Cell Fact 23(1):182 PMID: 38898430
- 2. Xu X et al.. 2025. N(7)-methylguanosine tRNA modification promotes gastric cancer progression by activating SDHAF4-dependent mitochondrial oxidative phosphorylation.. Cancer Lett 615:217566 PMID: 39965707
- 3. Kimbrough EM et al.. 2025. An RNA modification prevents extended codon-anticodon interactions from facilitating +1 frameshifting.. Nat Commun 16(1):7392 PMID: 40789848
- 4. Tomikawa C. 2018. 7-Methylguanosine Modifications in Transfer RNA (tRNA).. Int J Mol Sci 19(12) PMID: 30562954
- 5. Ribeiro FF et al.. 2016. Purine nucleosides in neuroregeneration and neuroprotection.. Neuropharmacology 104:226-42 PMID: 26577017
- 6. Rollenhagen C et al.. 2006. Nuclear import of spliceosomal snRNPs.. Can J Physiol Pharmacol 84(3-4):367-76 PMID: 16902583
- 7. Cowling VH. 2009. Regulation of mRNA cap methylation.. Biochem J 425(2):295-302 PMID: 20025612
- 8. Cech TR. 1990. Self-splicing of group I introns.. Annu Rev Biochem 59:543-68 PMID: 2197983
